Quick10K

⚲

Evercore

Filings

10-Q	2021-03-31	Filed 2021-05-06
10-K	2020-12-31	Filed 2021-02-25
10-Q	2020-09-30	Filed 2020-11-02
10-Q	2020-06-30	Filed 2020-08-04
10-Q	2020-03-31	Filed 2020-05-05
10-K	2019-12-31	Filed 2020-02-25
10-Q	2019-09-30	Filed 2019-10-31
10-Q	2019-06-30	Filed 2019-08-01
10-Q	2019-03-31	Filed 2019-05-02
10-K	2018-12-31	Filed 2019-02-22
10-Q	2018-09-30	Filed 2018-11-01
10-Q	2018-06-30	Filed 2018-08-01
10-Q	2018-03-31	Filed 2018-05-02
10-K	2017-12-31	Filed 2018-02-23
10-Q	2017-09-30	Filed 2017-11-02
10-Q	2017-06-30	Filed 2017-08-01
10-Q	2017-03-31	Filed 2017-05-09
10-K	2016-12-31	Filed 2017-02-24
10-Q	2016-09-30	Filed 2016-11-02
10-Q	2016-06-30	Filed 2016-08-04
10-Q	2016-03-31	Filed 2016-05-05
10-K	2015-12-31	Filed 2016-02-24
10-Q	2015-09-30	Filed 2015-11-02
10-Q	2015-06-30	Filed 2015-08-05
10-Q	2015-03-31	Filed 2015-05-06
10-K	2014-12-31	Filed 2015-02-27
10-Q	2014-09-30	Filed 2014-11-06
10-Q	2014-06-30	Filed 2014-08-08
10-Q	2014-03-31	Filed 2014-05-08
10-K	2013-12-31	Filed 2014-02-28
10-Q	2013-09-30	Filed 2013-11-12
10-Q	2013-06-30	Filed 2013-08-07
10-Q	2013-03-31	Filed 2013-05-08
10-K	2012-12-31	Filed 2013-02-27
10-Q	2012-09-30	Filed 2012-11-07
10-Q	2012-06-30	Filed 2012-08-08
10-Q	2012-03-31	Filed 2012-05-09
10-K	2011-12-31	Filed 2012-02-29
10-Q	2011-09-30	Filed 2011-11-08
10-Q	2011-06-30	Filed 2011-08-05
10-Q	2011-03-31	Filed 2011-04-29
10-K	2010-12-31	Filed 2011-03-09
10-Q	2010-09-30	Filed 2010-11-05
10-Q	2010-06-30	Filed 2010-08-06
10-Q	2010-03-31	Filed 2010-05-05
10-K	2009-12-31	Filed 2010-02-22

Reports

8-K	2021-02-03
8-K	2020-10-21
8-K	2020-07-22
8-K	2020-07-14
8-K	2020-06-16
8-K	2020-04-22
8-K	2020-01-29
8-K	2019-10-23
8-K	2019-10-22
8-K	2019-07-24
8-K	2019-06-18
8-K	2019-04-24
8-K	2019-01-30
8-K	2018-10-24
8-K	2018-10-22
8-K	2018-07-25
8-K	2018-06-11
8-K	2018-04-25
8-K	2018-04-24
8-K	2018-01-31

Evercore Financials

EVR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	204	244	183	101	151	162	259	137	147	244	298	124	193	239	352	226	250	278	449	292	247	446	559	351	410	440	610	416	415	434	800	348	385	314
Accounts Receivable	83	66	52	56	54	73	89	78	114	58	83	89	100	103	136	127	125	163	175	146	189	146	231	201	181	207	185	223	274	232	309	357	317	306
Inventory
PP&E	15	15	21	27	45	47	50	28	28	28	54	28	31	32	77	41	45	48	91	48	45	46	105	56	63	68	139	68	67	69	171	93	104	113
Assets	1,042	1,070	1,044	942	974	1,029	1,145	976	1,033	1,103	1,181	1,045	1,148	1,224	1,447	1,289	1,300	1,330	1,479	1,285	1,307	1,462	1,662	1,433	1,451	1,561	1,585	1,418	1,613	1,706	2,126	1,845	1,940	2,211
Accounts Payable
Long-Term Debt
Liabilities	542	587	555	448	484	535	605	434	512	550	581	458	533	605	730	614	612	641	772	646	664	762	879	648	752	833	789	643	762	806	1,118	839	965	1,208
Stockholders' Equity	412	401	408	412	406	410	429	436	416	444	503	491	527	513	551	490	487	480	505	420	406	454	527	560	459	476	544	550	624	668	758	768	738	765


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	148	169	114	107	176	157	1	155	211	191	222	152	222	231	326	242	273	313	411	260	355	391	450	392	375	412	545	468	454	385		419	535	408
Cost of Revenue
Gross Profit
R&D
SG&A
Tax	6	11	0	1	10	7	19	23	17	13	26	8	15	15	31	6	17	7	47	19	31	39	40	45	22	29	189	20	26	18	61	51	32	42
Net Income	5	2	-1	-3	12	7	25	8	22	18	23	13	30	25	39	6	16	7	30	8	34	47	60	95	26	60	-1	110	82	59	192	78	97	53


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		102	38	-89	92	44	-47	-85	79	124	80	-116	104	102	127	-79	125	97	214	-117	126	237	170	-81	236	170	191	-41	215	136		-413	278	226
Cash Investing		-25	-72	29	-3	2	-3	2	-2	-5	-3	1	-6	-0	30	5	-6	-18	-7	-6	-27	-9	-7	-1	-6	-64	18	28	-155	-63		80	-12	-422
Cash Financing		-35	-25	-22	-37	-37	-13	-39	-66	-23	-22	-58	-31	-52	-39	-51	-97	-44	-32	-32	-134	-24	-43	-124	-171	-82	-42	-192	-57	-57		-123	-224	129